Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.05 (11.111%)
Market Cap: £4.43m
SUN Live PriceLast checked at - London Stock Exchange

Intraday Surgical Innovations Share Chart

Acquisition

7 Nov 2016 07:00

RNS Number : 4371O
Surgical Innovations Group PLC
07 November 2016
Β 

Β 

7 November 2016

Surgical Innovations Group plcΒ 

("SI Group")

Β 

Acquisition

Β 

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical technology for minimally invasive surgery, has completed the acquisition of the laparoscopic instruments business and related assets of Surgical Dynamics Limited ("SDL") for a cash consideration of approximately Β£0.36m, including assumed debt of not greater than Β£0.05m. Consideration will be funded from existing cash resources.

Β 

SDL is a privately owned company based in County Durham, and specialises in the design, development and rapid prototyping of a range of medical products. Revenues for the year ended 31 December 2015 amounted to Β£0.12m and loss before tax was Β£0.17m. In addition to these development activities, SDL has introduced specialist production processes including metal injection moulding of medical components, which are of particular relevance to SI Group and others in this sector.

Β 

Following this transaction, all of SDL's business in the production and distribution of single-use laparoscopic products will be relocated to the SI Group site at Leeds, and SDL has undertaken to offer any new products developed in the laparoscopic field exclusively to SI Group for a minimum period of three years.

Β 

Managing Director of SI Group, Melanie Ross, commented: "We are delighted to be working with SDL and its owners to further broaden our product portfolio, and bring additional precision manufacturing techniques to our facility at Leeds. This is an exciting opportunity to increase our appeal to distributors and end-user customers across a number of geographical markets, and will further enhance our competitive position in the UK and elsewhere. This is the first acquisition by SI Group following board changes over the last twelve months, and we continue to seek further opportunities to build on our expanding market presence."

Β 

Β 

For further information please contact:

Β 

Surgical Innovations Group Plc

www.sigroupplc.com

Nigel Rogers, Executive Chairman

Tel: 0113 230 7597

Melanie Ross, Group FD & Managing Director, SI Ltd

WH Ireland Limited (NOMAD & Broker)

James Joyce / Ed Kennedy (Nomad)

Β 

Tel: 020 7220 1666

Β 

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Natalie Bruce

Mob: 07884 666 994

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQUNVVRNBAARAA
Date   Source Headline
18th Dec 20129:24 amRNSDirectors' dealings and issue of equity
18th Dec 20127:00 amRNSAppointments to the Clinical Advisory Board
29th Oct 20127:00 amRNSFirst PretzelFlex® orders shipped to CareFusion
11th Oct 20127:00 amRNSSuccessful exhibition at ISHA in the US
18th Sep 20127:00 amRNSHalf Yearly Report
4th Sep 20127:00 amRNSNotice of Results
30th Aug 20122:14 pmRNSHolding(s) in Company
26th Jun 20127:00 amRNSGrant of options
19th Jun 20123:33 pmRNSResult of AGM
19th Jun 20127:00 amRNSAGM Statement
18th Jun 20127:00 amRNSOEM distribution agreement with CareFusion
31st May 20127:00 amRNSUK distribution agreement
25th May 201211:58 amRNSDirectorate Change
22nd May 20127:00 amRNSPublication of Annual Report and Notice of AGM
1st May 20127:00 amRNSInvestor site visit
24th Apr 20127:00 amRNSFinal Results
20th Apr 20127:00 amRNSNotice of Results
15th Mar 20127:00 amRNSFDA 510(k) approval for reusable PretzelFlexT
23rd Feb 20124:54 pmRNSHolding(s) in Company
17th Feb 20124:36 pmRNSDirector/PDMR Shareholding
14th Feb 20125:49 pmRNSIssue of Equity
1st Feb 20127:00 amRNSRe: US contract and FDA approval
23rd Jan 20127:01 amRNSTrading Statement
2nd Dec 20117:00 amRNSInvestor Site Visit
3rd Nov 20117:00 amRNSIssue of Equity
1st Nov 20117:00 amRNSConfirmation of successful RGF bid
21st Sep 20114:49 pmRNSIssue of Equity
14th Sep 20117:00 amRNSHalf Yearly Report
1st Sep 20115:23 pmRNSHolding(s) in Company
1st Sep 20117:00 amRNSRe Agreement
1st Sep 20117:00 amRNSAgreement with Surgical Innovations Group
24th Aug 20117:00 amRNSNotice of Results
22nd Jul 20117:00 amRNSRe Agreement
20th Jun 20112:42 pmRNSResult of AGM
20th Jun 20117:00 amRNSAGM Statement
13th Jun 20115:08 pmRNSHolding(s) in Company
11th May 20115:12 pmRNSIssue of Equity
3rd May 20114:05 pmRNSIssue of Equity
26th Apr 20114:34 pmRNSDirector/PDMR Shareholding
21st Apr 201111:47 amRNSHolding(s) in Company
19th Apr 20117:00 amRNSFinal Results
28th Mar 201112:04 pmRNSHolding(s) in Company
24th Mar 201112:17 pmRNSHolding(s) in Company
24th Feb 20113:40 pmRNSHolding(s) in Company
15th Feb 20114:45 pmRNSExercise of Options
14th Feb 20117:00 amRNSRe Contract
14th Jan 201110:08 amRNSTrading Statement
1st Dec 20107:00 amRNSChange of Adviser
29th Oct 201012:11 pmRNSTotal Voting Rights
27th Oct 20102:32 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.